5.3.3.1	(17S)-Spiro[5alpha-androstane-17,2'-oxiran]-3-one	potent irreversible active-site directed	90234	
5.3.3.1	(17S)-Spiro[estra-1,3,5(10),6,8-pentaene-17,2'-oxiran]-3-ol	active-site-directed, irreversible	90235	
5.3.3.1	(17S)-Spiro[estra-1,3,5(10)-triene-17,2'-oxiran]-3-ol	potent irreversible active-site directed	95401	
5.3.3.1	(3S)-Spiro-[5alpha-androstane-3,2'-oxiran]-17-one	-	95435	
5.3.3.1	10beta-(1-Oxoprop-2-ynyl)oestr-4-ene-3,17-dione	irreversible, time-dependent, active-site directed	90633	
5.3.3.1	17-beta-Acetoxy-5alpha-androstan-3-one	-	90701	
5.3.3.1	17beta-(1-Oxoprop-2-ynyl)androst-4-en-3-one	irreversible, time-dependent, active-site directed	90722	
5.3.3.1	17beta-estradiol	competitive	745	
5.3.3.1	17beta-estradiol	IC50: 0.0003 mM	745	
5.3.3.1	17beta-Hydroxy-5,10-seco-oestr-4-yne-3,10-dione	irreversible, time-dependent, active-site directed	90728